NFATC1 and B-cell chronic lymphocytic leukemia: These studies were further extended, demonstrating that NFAT2 controls multiple anergy-associated genes, BCR expression, and Ca2+ response in CLL B cells (84) and that knockdown of STAT3 significantly impaired the ability of CLL B cells to produce IL-10 and reverse T-cell dysfunction (85).